Personalized Health Self-Management Training for Colorectal Cancer Survivors

Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Aug 2, 2023

Keywords

ClinConnect Summary

This clinical trial is comparing two types of self-management training programs for patients with colorectal cancer. The goal is to find out if a personalized self-management training (PSMT) program is more effective in helping patients stick to healthy behavior recommendations than a standardized version (SSMT). The study will involve 120 colorectal cancer patients who will be randomly assigned to one of the two training programs led by trained occupational therapists. Both programs will last for 6 weeks and focus on improving lifestyle factors like diet and physical activity.

To participate, individuals need to be at least 18 years old and have been diagnosed with Stage I-III colorectal cancer within the past year. They should be interested in working on at least one lifestyle change and have moderate to low adherence to healthy behaviors, as measured by a specific scale. Participants can expect to engage in a supportive training environment where they will learn ways to improve their health and well-being. It's important to note that individuals with certain cognitive impairments or those planning to undergo active cancer treatment within the next six months are not eligible to join the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥18 years at the time of consent.
• • 2. History of Stage I-IV colorectal cancer (CRC) within the past 5 years prior to enrollment.
• • 3. Ability to speak, write, and read English sufficiently to allow for program participation.
• • 4. Identified by self-report as having willingness and interest to work on at least one lifestyle-related risk factor. Lifestyle-related risk factors include diet, physical activity, body composition, alcohol use.
• • 5. Scoring ≤3.5 on the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Health Behavior Adherence Scale or in the low-to-moderate range in any subcategory consistent with moderate to low adherence to healthy behavior recommendations (HBRs).
• • 6. Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
• Exclusion Criteria:
• • 1. Cognitive or mental impairments that in the opinion of the Principal Investigator or study physician would hinder the program participation.
• • 2. Planning to have active anti-cancer treatment (including radiation, chemo, and/or major surgery) within 6 months after initial interventional or control session. Long-term hormonal/biologic therapy is acceptable.